Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

JAZZ

Jazz Pharmaceuticals plc

Jun 21 • 04:00PM ET

107.97

Dollar change +0.61
Percentage change 0.57	%

Healthcare • Biotechnology • Ireland • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IJH VTI COWZ VB VBR VXF MDY SPMD IJJ VHT

Scroll to Statements

Index	-	P/E	23.49	EPS (ttm)	4.60	Insider Own	3.32%	Shs Outstand	62.26M	Perf Week	-4.20%
Market Cap	6.81B	Forward P/E	5.19	EPS next Y	20.81	Insider Trans	0.15%	Shs Float	60.97M	Perf Month	0.93%
Income	330.79M	PEG	5.46	EPS next Q	4.80	Inst Own	96.03%	Short Float	5.60%	Perf Quarter	-13.00%
Sales	3.84B	P/S	1.77	EPS this Y	1.40%	Inst Trans	-0.76%	Short Ratio	4.54	Perf Half Y	-11.61%
Book/sh	58.65	P/B	1.84	EPS next Y	12.22%	ROA	2.96%	Short Interest	3.41M	Perf Year	-15.83%
Cash/sh	28.84	P/C	3.74	EPS next 5Y	4.30%	ROE	9.41%	52W Range	103.01 - 146.70	Perf YTD	-12.22%
Dividend Est.	-	P/FCF	6.73	EPS past 5Y	-3.53%	ROI	3.73%	52W High	-26.40%	Beta	0.58
Dividend TTM	-	Quick Ratio	1.78	Sales past 5Y	15.52%	Gross Margin	73.55%	52W Low	4.82%	ATR (14)	3.11
Dividend Ex-Date	-	Current Ratio	2.15	EPS Y/Y TTM	310.66%	Oper. Margin	15.83%	RSI (14)	46.58	Volatility	2.31% 2.61%
Employees	2800	Debt/Eq	1.57	Sales Y/Y TTM	2.81%	Profit Margin	8.61%	Recom	1.53	Target Price	178.72
Option/Short	Yes / Yes	LT Debt/Eq	1.40	EPS Q/Q	-124.85%	Payout	0.00%	Rel Volume	2.13	Prev Close	107.36
Sales Surprise	-5.45%	EPS Surprise	-35.87%	Sales Q/Q	1.03%	Earnings	May 01 AMC	Avg Volume	751.56K	Price	107.97
SMA20	-0.09%	SMA50	-1.22%	SMA200	-10.60%	Trades		Volume	1,600,099	Change	0.57%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-05-24	Initiated	Goldman	Buy	$169
Jan-03-24	Initiated	Robert W. Baird	Outperform	$160
Nov-27-23	Downgrade	UBS	Buy → Neutral	$170 → $135
Sep-29-23	Initiated	Raymond James	Mkt Perform
Jun-12-23	Resumed	Wells Fargo	Equal Weight	$184 → $140
Dec-09-22	Upgrade	Goldman	Neutral → Buy	$192 → $190
Jun-14-22	Initiated	UBS	Buy	$194
Apr-06-22	Downgrade	Goldman	Buy → Neutral	$202 → $196
Nov-19-21	Resumed	Goldman	Buy	$198
Oct-07-21	Resumed	Jefferies	Buy	$172
Oct-05-21	Initiated	Citigroup	Buy	$200
Sep-23-21	Initiated	Needham	Buy	$220
May-19-21	Resumed	JP Morgan	Overweight	$183 → $206
Apr-07-21	Resumed	RBC Capital Mkts	Outperform	$186
Feb-05-21	Reiterated	H.C. Wainwright	Buy	$195 → $207
Feb-03-21	Upgrade	Piper Sandler	Neutral → Overweight	$150 → $175
Jan-29-21	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Dec-16-20	Initiated	UBS	Buy	$174
Nov-03-20	Reiterated	H.C. Wainwright	Buy	$185 → $195
Oct-09-20	Reiterated	H.C. Wainwright	Buy	$175 → $185

Show Previous Ratings

Jun-21-24 07:00AM	Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs (BioPharma Dive)
06:33AM	Jazz Pharmaceuticals essential tremor drug falls flat in Phase IIb trial (Clinical Trials Arena)
Jun-20-24 04:08PM	Jazz Dives But Key Rival Praxis Surges On Essential Tremor Drug Failure (Investor's Business Daily)
10:08AM	Jazz Dives And Takes Praxis With It On Essential Tremor Drug Failure (Investor's Business Daily)
07:45AM	Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor (PR Newswire)
06:13AM	Loading…
Jun-14-24 06:13AM	3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition (InvestorPlace)
Jun-11-24 10:42AM	Load Up, Says Goldman Sachs About These 2 Strong Buy Stocks (TipRanks)
Jun-03-24 02:27PM	7 Overlooked Stocks Offering Long-Term Stability From the Shadows (InvestorPlace)
Jun-01-24 08:05AM	Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial Evaluating Zanidatamab in Previously Treated HER2-Positive Biliary Tract Cancer at ASCO 2024 (PR Newswire)
May-31-24 11:31AM	Why Is Jazz (JAZZ) Down 3.5% Since Last Earnings Report? (Zacks)
May-30-24 07:30AM	Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024 (PR Newswire)
May-29-24 04:15PM	Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences (PR Newswire)
07:45AM	Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer (PR Newswire)
May-28-24 07:00AM	NodThera Announces Appointment of Daniel Swisher as Chief Executive Officer (GlobeNewswire)
May-26-24 10:09AM	3 Cannabis Stocks to Buy Now: May 2024 (InvestorPlace)
06:00AM	Loading…
May-23-24 06:00AM	7 Blue-Chip Stocks to Buy Now: May 2024 (InvestorPlace)
May-22-24 07:01PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
04:00PM	Jazz Pharmaceuticals Announces Collaboration With Life Science Cares To Improve the Wellbeing of Under Resourced Communities Through Employee Volunteerism (ACCESSWIRE)
May-17-24 02:32PM	3 Cheap Blue-Chip Stocks to Buy Now: May 2024 (InvestorPlace)
May-09-24 09:19AM	7 Cannabis Stocks to Buy for a Smoking-Hot 2024 (InvestorPlace)
May-08-24 04:30PM	The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy? (InvestorPlace)
01:22PM	Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-07-24 05:37PM	Jazz Pharmaceuticals Insider Sold Shares Worth $548,250, According to a Recent SEC Filing (MT Newswires)
10:57AM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript (Insider Monkey)
May-06-24 09:29AM	Jazz (JAZZ) International Revenue Performance Explored (Zacks)
May-03-24 12:41PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
11:49AM	UBS Adjusts Price Target on Jazz Pharmaceuticals to $117 From $121, Maintains Neutral Rating (MT Newswires)
May-02-24 11:26AM	Jazz (JAZZ) Q1 Earnings & Sales Fall Short of Estimates (Zacks)
03:53AM	Jazz Pharmaceuticals Q1 Adjusted Earnings Decline, Revenue Rises; Reaffirms 2024 Outlook (MT Newswires)
May-01-24 08:56PM	JAZZ Stock Earnings: Jazz Pharmaceuticals Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
07:00PM	Loading…
07:00PM	Jazz (JAZZ) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
04:24PM	Jazz: Q1 Earnings Snapshot (Associated Press Finance)
04:10PM	Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference (PR Newswire)
04:05PM	Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance (PR Newswire)
Apr-30-24 09:50AM	Jazz Pharmaceuticals Focuses on Taking Actions To Positively Impact the Planet This Earth Month (ACCESSWIRE)
Apr-24-24 04:05PM	Jazz Pharmaceuticals to Present Data Across Growing Oncology Pipeline and Portfolio at ASCO 2024 (PR Newswire)
10:01AM	Jazz Pharmaceuticals (JAZZ) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
05:21AM	3 No-Brainer Stocks to Buy With $300 Right Now (Motley Fool)
Apr-23-24 11:15AM	Jazz Pharmaceuticals Employees Wear Purple To Support Epilepsy Awareness and Community (ACCESSWIRE)
Apr-17-24 04:15PM	Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024 (PR Newswire)
Apr-10-24 07:45AM	Jazz Pharmaceuticals to Showcase Expansive Neuroscience Portfolio at American Academy of Neurology Annual Meeting (PR Newswire)
Apr-04-24 09:15AM	Following the Money Trail: Where are Hedge Funds Investing? (Insider Monkey)
Apr-02-24 07:30AM	Jazz Pharmaceuticals Completes Zanidatamab Biologics License Application for Previously Treated HER2-Positive Metastatic Biliary Tract Cancer (PR Newswire)
Mar-29-24 11:30AM	Why Is Jazz (JAZZ) Up 1.3% Since Last Earnings Report? (Zacks)
Mar-28-24 10:15AM	Cancer and the Combination Approach (ACCESSWIRE)
Mar-20-24 10:15AM	Jazz Pharmaceuticals Celebrates International Womens Day (ACCESSWIRE)
Mar-18-24 03:28PM	20 States with the Cheapest Weed in America (Insider Monkey)
Mar-17-24 08:50AM	30 Biggest Biotechnology Companies in the World (Insider Monkey)
Mar-14-24 12:00PM	Exploring How Jazz Pharmaceuticals Honored U.S. Black History Month (ACCESSWIRE)
10:00AM	Unlocking Jazz Pharmaceuticals' Potential: A Roadmap for Growth (GuruFocus.com)
Mar-13-24 02:25PM	7 Biotech Stocks to Buy as Sector Rotation Ramps Up (InvestorPlace)
Mar-12-24 05:34PM	11 Stocks Insiders are Buying Now (Insider Monkey)
04:15PM	Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024 (PR Newswire)
Mar-09-24 11:15AM	Morningstar \| A Weekly Summary of Stock Ideas and Developments in the Companies We Cover (Morningstar Research)
Mar-07-24 01:51PM	Analyst Report: Jazz Pharmaceuticals plc (Morningstar Research)
01:10PM	Q4 2023 Zymeworks Inc Earnings Call (Thomson Reuters StreetEvents)
10:08AM	10 Mid-Cap Stocks with Insider Purchases (Insider Monkey)
Feb-29-24 10:45AM	Jazz (JAZZ) Q3 Earnings Lag, Revenues in Line With Estimates (Zacks) -8.33%
10:35AM	Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-28-24 06:30PM	Here's What Key Metrics Tell Us About Jazz (JAZZ) Q4 Earnings (Zacks)
05:20PM	Jazz Pharmaceuticals (JAZZ) Q4 Earnings Lag Estimates (Zacks)
04:33PM	Jazz Pharmaceuticals PLC (JAZZ) Reports Strong Revenue Growth and Robust Pipeline Progress (GuruFocus.com)
04:29PM	Jazz: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2023 Financial Results and Provides 2024 Financial Guidance (PR Newswire)
Feb-27-24 10:15PM	Q4 2023 Ligand Pharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
07:45AM	Jazz Pharmaceuticals Appoints Patrick Kennedy to its Board of Directors (PR Newswire)
Feb-24-24 05:06AM	4 Exhilarating Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip (Motley Fool)
Feb-23-24 09:15AM	Exploring Analyst Estimates for Jazz (JAZZ) Q4 Earnings, Beyond Revenue and EPS (Zacks)
Feb-21-24 08:50AM	Jazz Pharmaceuticals Names Eli Lillys Philip Johnson as Next CFO (The Wall Street Journal)
07:45AM	Jazz Pharmaceuticals Appoints Philip Johnson as Chief Financial Officer (PR Newswire)
Feb-20-24 05:00PM	3 Cannabis Stocks That Could Be Multibaggers in the Making: February Edition (InvestorPlace)
04:15PM	Jazz Pharmaceuticals to Participate in Upcoming March Investor Conferences (PR Newswire)
Feb-14-24 04:15PM	Jazz Pharmaceuticals to Report 2023 Full Year and Fourth Quarter Financial Results on February 28, 2024 (PR Newswire)
Feb-13-24 10:15AM	Listen to How "Jazz Remix" Fosters a Positive Employee Experience at Jazz Pharmaceuticals (ACCESSWIRE)
Feb-09-24 09:15AM	How This CEO Built a Top 50 Pharma Company Focusing on Culture Day 1 (ACCESSWIRE)
Feb-07-24 07:35AM	3 Biotech Stocks to Buy on the Dip: February 2024 (InvestorPlace)
02:00AM	Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program (PR Newswire)
Feb-03-24 05:06AM	4 Eye-Catching Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip (Motley Fool)
Jan-31-24 03:33PM	25 Most Cannabis Consuming-Countries in the World (Insider Monkey)
12:03PM	Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for January 2024 (InvestorPlace)
Jan-22-24 05:16AM	2 Incredible Growth Stocks That Are Screaming Buys for 2024 (Motley Fool)
Jan-18-24 05:37AM	Bank of America Says These 3 Healthcare Stocks Have up to ~160% Upside Potential (TipRanks)
Jan-13-24 05:06AM	4 Remarkable Growth Stocks You'll Regret Not Buying in the Wake of the Nasdaq Bear Market Dip (Motley Fool)
Dec-28-23 10:06PM	7 Growth Stocks Poised to Thrive in a Post-Fed Pivot World (InvestorPlace)
Dec-22-23 12:07PM	Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals (Zacks)
11:16AM	Jazz Pharmaceuticals' Post-Traumatic Stress Disorder Drug Disappoints In Mid-Stage Study (Benzinga)
Dec-21-23 04:17PM	UPDATE 1-Jazz Pharmaceuticals' PTSD drug fails in mid-stage trial (Reuters)
04:09PM	Jazz Pharmaceuticals' PTSD drug fails in mid-stage trial (Reuters)
04:05PM	Jazz Pharmaceuticals Provides Update on Phase 2 Trial of Investigational JZP150 in Adult Patients with Post-Traumatic Stress Disorder (PR Newswire)
Dec-20-23 04:15PM	Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
05:21AM	3 No-Brainer Stocks to Buy With $500 Right Now (Motley Fool)
Dec-08-23 01:20PM	Jazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS 2023 Showcasing Potential of Zanidatamab in HER2+/HR+ Metastatic Breast Cancer (PR Newswire)
11:30AM	Why Is Jazz (JAZZ) Up 2.6% Since Last Earnings Report? (Zacks)
09:15AM	Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report: Serving our Global Communities (ACCESSWIRE)
Dec-01-23 09:02AM	Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting (PR Newswire)
Nov-30-23 07:45AM	Jazz Pharmaceuticals to Present New Data Highlighting Advancements in Solid Tumors and Rare Blood Cancers at Upcoming Oncology Meetings (PR Newswire)
Nov-29-23 11:15AM	Jazz Pharmaceuticals' 2022 Corporate Sustainability and Social Impact Report: Using Natural Resources Responsibly (ACCESSWIRE)
Nov-28-23 08:48AM	3 Top-Rated Biotech Stocks That Analysts Are Loving Now (InvestorPlace)
Nov-27-23 09:49AM	5 Best Upside Stocks To Buy Now (Insider Monkey)
Nov-15-23 05:21AM	3 No-Brainer Stocks to Buy With $200 Right Now (Motley Fool)

Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Carr Patricia	SVP, Chief Accounting Officer	Jun 07 '24	Sale	108.83	163	17,738	6,596	Jun 11 08:15 PM
Patil Neena M	EVP & Chief Legal Officer	May 03 '24	Sale	109.65	5,000	548,250	36,629	May 07 05:31 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 07 '24	Sale	116.98	1,768	206,821	6,596	Mar 08 06:07 PM
Carr Patricia	SVP, Chief Accounting Officer	Mar 06 '24	Sale	119.64	1,936	231,628	8,364	Mar 08 06:07 PM
Johnson Philip L	EVP & Chief Financial Officer	Mar 01 '24	Buy	119.65	12,000	1,435,800	27,932	Mar 05 07:28 PM
Cook Jennifer E.	Director	Dec 04 '23	Sale	119.27	417	49,736	6,888	Dec 06 04:31 PM
Smith Mark Douglas	Director	Dec 04 '23	Sale	119.27	417	49,736	6,888	Dec 06 04:39 PM
Patil Neena M	EVP & Chief Legal Officer	Sep 01 '23	Sale	144.25	1,500	216,375	29,186	Sep 06 05:09 PM
Carr Patricia	SVP, Chief Accounting Officer	Aug 29 '23	Sale	143.47	142	20,373	5,986	Aug 31 06:44 PM
Patil Neena M	EVP & Chief Legal Officer	Aug 15 '23	Sale	139.59	750	104,695	30,686	Aug 17 05:21 PM
McSharry Heather Ann	Director	Aug 14 '23	Sale	138.16	1,344	185,685	16,778	Aug 15 05:52 PM
ENRIGHT PATRICK G	Director	Aug 14 '23	Sale	138.16	1,241	171,455	20,946	Aug 15 05:45 PM
Sohn Catherine A.	Director	Aug 14 '23	Sale	138.16	1,241	171,455	14,868	Aug 15 06:02 PM
O'Keefe Kenneth W	Director	Aug 14 '23	Sale	138.16	1,241	171,455	24,723	Aug 15 07:49 PM
Winningham Rick E	Director	Aug 14 '23	Sale	138.16	1,241	171,455	10,444	Aug 15 06:08 PM
Gray Peter	Director	Aug 14 '23	Sale	138.16	1,241	171,455	16,068	Aug 15 05:47 PM
RIEDEL NORBERT G	Director	Aug 14 '23	Sale	138.16	1,241	171,454	13,705	Aug 15 05:58 PM
Cook Jennifer E.	Director	Aug 14 '23	Sale	138.16	1,241	171,454	7,305	Aug 15 05:44 PM
ORiordan Anne	Director	Aug 14 '23	Sale	138.16	1,241	171,454	12,551	Aug 15 07:51 PM
Smith Mark Douglas	Director	Aug 14 '23	Sale	138.16	1,241	171,454	7,305	Aug 15 06:00 PM
Carr Patricia	SVP, Chief Accounting Officer	Aug 14 '23	Sale	138.16	158	21,829	6,128	Aug 15 05:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JAZZ

Jazz Pharmaceuticals plc

Upgrade your FINVIZ experience